Results 241 to 250 of about 3,363,784 (294)

Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach. [PDF]

open access: yesBJU Int
Siva J   +12 more
europepmc   +1 more source

Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non-Invasive Diagnosis of Bladder Cancer. [PDF]

open access: yesCancer Sci
Wang T   +13 more
europepmc   +1 more source

INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol. [PDF]

open access: yesBJU Int
Lister-Whelan R   +13 more
europepmc   +1 more source

The impact of <i>ERBB2</i> alterations in muscle-invasive bladder cancer after neoadjuvant chemotherapy. [PDF]

open access: yesBJUI Compass
Burgess EF   +7 more
europepmc   +1 more source

Dose-Escalated Radiation Therapy for Muscle-Invasive Bladder Cancer: A Retrospective Analysis. [PDF]

open access: yesAdv Radiat Oncol
Chan L   +8 more
europepmc   +1 more source

Bladder cancer

Critical Reviews in Oncology/Hematology, 2002
Bladder cancer is the second most frequent tumour of the urogenital tract. Tobacco smoke has been shown to increase the risk of bladder cancer two- to fivefold as well as the exposure to metabolites of aniline dyes and other aromatic amines. Seventy-five per cent of bladder cancers are superficial at initial presentation, limited to the mucosa ...
Filippo, de Braud   +6 more
openaire   +4 more sources

Bladder cancer

The Lancet, 2016
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy